Europol Joint Report on a new psychoactive substance: Carfentanil

2017

European Monitoring Centre for Drugs and Drug Addiction

Effect of Intranasal vs Intramuscular Naloxone on Opioid Overdose A Randomized Clinical Trial

2019

Paul Dietze, PhD, Marianne Jauncey, MPH (Hons), Allison Salmon, PhD, Mohammadreza Mohebbi, PhD, Julie Latimer, BN (Hons), Ingrid van Beek, MD, Colette McGrath, MHM, and Debra Kerr, PhD

Drug Overdose Deaths Involving Fentanyl, 2011–2016

2019

Merianne Rose Spencer, M.P.H., Margaret Warner, Ph.D., and Brigham A. Bastian, B.S., National Center for Health Statistics; James P. Trinidad, M.P.H., M.S., U.S. Food and Drug Administration; and Holly Hedegaard, M.D., M.S.P.H., National Center for Health Statistics

Drug and Opioid-Involved Overdose Deaths — United States, 2017–2018

2020

Nana Wilson, PhD; Mbabazi Kariisa, PhD; Puja Seth, PhD; Herschel Smith IV, MPH; Nicole L. Davis, PhD

Deaths Involving Fentanyl, Fentanyl Analogs, and U-47700 — 10 States, July–December 2016

2017

Julie K. O’Donnell, PhD, John Halpin, MD, Christine L. Mattson, PhD, Bruce A. Goldberger, PhD, and R. Matthew Gladden, PhD

Death Rates from Unintentional and Undetermined Prescription Opioid Overdoses and Dispensing Rates of Controlled Prescription Opioid Analgesics - 2011-2015

2017

Scott K Proescholdbell, Mary E Cox, Alex Asbun

Characteristics of Fentanyl Overdose — Massachusetts, 2014–2016

2017

Nicholas J. Somerville, MD; Julie O’Donnell, PhD; R. Matthew Gladden, PhD; Jon E. Zibbell, PhD; Traci C. Green, PhD; Morgan Younkin, MD; Sarah Ruiz, MSW; Hermik Babakhanlou-Chase, MPH; Miranda Chan, MPH; Barry P. Callis, MSW; Janet Kuramoto-Crawford, PhD; Henry M. Nields, MD, PhD; Alexander Y. Walley, MD

Vital Signs: Changes in Opioid Prescribing in the United States, 2006–2015

2017

Gery P. Guy Jr., PhD; Kun Zhang, PhD; Michele K. Bohm, MPH; Jan Losby, PhD; Brian Lewis; Randall Young, MA; Louise B. Murphy, PhD; Deborah Dowell, MD

Buprenorphine physician supply: Relationship with state-level prescription opioid mortality

2017

Hannah K. Knudsen, Jennifer R. Havens, Michelle R. Lofwall, Jamie L. Studts, Sharon L. Walsh

Buprenorphine Exposures Among Children and Adolescents Reported to US Poison Control Centers

2018

Sara Post, Henry A. Spiller, Marcel J. Casavant, Thitphalak Chounthirath and Gary A. Smith

Association of Law Enforcement Seizures of Heroin, Fentanyl, and Carfentanil With Opioid Overdose Deaths in Ohio, 2014-2017

2019

Jon E. Zibbell, PhD, Arnie P. Aldridge, PhD, Dennis Cauchon, Jolene DeFiore-Hyrmer, PhD, MPH, and Kevin P. Conway, PhD

An Expanding World of Novel Psychoactive Substances: Opioids

2017

Jolanta B. Zawilska

Addressing the Fentanyl Threat to Public Health

2017

Richard G. Frank, Ph.D., and Harold A. Pollack, Ph.D.

ACMT and AACT Position Statement: Preventing Occupational Fentanyl and Fentanyl Analog Exposure to Emergency Responders

2017

Michael J. Moss, Brandon J. Warrick, Lewis S. Nelson, Charles A. McKay, Pierre-André Dubé, Sophie Gosselin, Robert B. Palmer, and Andrew I. Stolbach

Opioid Misuse Increases Among Older Adults

2017

SAMHSA

Opioid Overdose Outbreak — West Virginia, August 2016

2017

Joel Massey, MD; Michael Kilkenny, MD; Samantha Batdorf, MPH; Sarah K. Sanders, PhD; Debra Ellison; John Halpin, MD; R. Matthew Gladden, PhD; Danae Bixler, MD; Loretta Haddy, PhD; Rahul Gupta, MD

Opioid prescribing patterns among medical providers in the United States, 2003-17: retrospective, observational study

2020

Mathew V Kiang, Keith Humphreys, Mark R Cullen, Sanjay Bas

Notes from the Field: Opioid-Involved Overdose Deaths with Fentanyl or Fentanyl Analogs Detected — 28 States and the District of Columbia, July 2016–December 2018

2020

Julie O’Donnell, PhD; R. Matt Gladden, PhD; Bruce A. Goldberger, PhD; Christine L. Mattson, PhD; Mbabazi Kariisa, PhD

Opportunities to Prevent Overdose Deaths Involving Prescription and Illicit Opioids, 11 States, July 2016–June 2017

2018

Christine L. Mattson, PhD; Julie O’Donnell, PhD; Mbabazi Kariisa, PhD; Puja Seth, PhD; Lawrence Scholl, PhD; R. Matthew Gladden, PhD

Overdose Deaths Involving Fentanyl and Fentanyl Analogs — New York City, 2000–2017

2019

Cody Colon-Berezin, MSPH; Michelle L. Nolan, MPH; Jaclyn Blachman-Forshay, MPH; Denise Paone, EdD

Overdose Deaths Related to Fentanyl and Its Analogs — Ohio, January–February 2017

2017

Raminta Daniulaityte, PhD; Matthew P. Juhascik, PhD; Kraig E. Strayer; Ioana E. Sizemore, PhD; Kent E. Harshbarger, MD, JD; Heather M. Antonides; Robert R. Carlson, PhD

Notes from the Field: Overdose Deaths with Carfentanil and Other Fentanyl Analogs Detected — 10 States, July 2016–June 2017

2018

Julie O’Donnell, PhD; R. Matthew Gladden, PhD; Christine L. Mattson, PhD; Mbabazi Kariisa, PhD

Notes from the Field: Pediatric Emergency Department Visits for Buprenorphine/Naloxone Ingestion — United States, 2008–2015

2016

Daniel S. Budnitz, MD; Maribeth C. Lovegrove, MPH; Mathew R.P. Sapiano, PhD; Justin Mathew, PharmD; Scott R. Kegler, PhD; Andrew I. Geller, MD; Christian Hampp, PhD

Prescription opioid dispensing and prescription opioid poisoning: Population data from Victoria, Australia 2006 to 2013

2016

Janneke Berecki‐Gisolf, Behrooz Hassani‐Mahmooei, Angela Clapperton, Roderick McClure

The 2016 Heroin Signature Program Report: DEA Intelligence Report Copy

2018

DEA

Prescription Opioid Exposures Among Children and Adolescents in the United States: 2000–2015

2017

Jakob D. Allen, Marcel J. Casavant, MD, Henry A. Spiller, MS, D.ABAT, Thiphalak Chounthirath, MS, Nichole L. Hodges, PhD, Gary A. Smith, MD, DrPH

Prescription opioid use and misuse among adolescents and young adults in the United States: A national survey study

2019

Joel D. Hudgins, John J. Porter, Michael C. Monuteaux, Florence T. Bourgeois

Racial/Ethnic and Age Group Differences in Opioid and Synthetic Opioid–Involved Overdose Deaths Among Adults Aged ≥18 Years in Metropolitan Areas — United States, 2015–2017

2019

Kumiko M. Lippold, PhD; Christopher M. Jones, PharmD; Emily O’Malley Olsen, PhD; Brett P. Giroir, MD

Rapid widespread distribution of intranasal naloxone for overdose prevention

2017

Desiree Madah-Amiri, Thomas Clausen, Philipp Lobmaier

QuickStats: Rates of Drug Overdose Deaths Involving Heroin,* by Selected Age Groups — United States, 2006–2015

2017

National Center for Health Statistics

Report on the Risk Assessment of Acryloylfentanyl

2017

European Monitoring Centre for Drugs and Drug Addiction

Report on the Risk Assessment of Furanylfentanyl

2017

European Monitoring Centre for Drugs and Drug Addiction

Sold as Heroin: Perceptions and Use of an Evolving Drug in Baltimore, MD

2017

Sarah G. Mars, Ph.D; Jeff Ondocsin, M.A.; Daniel Ciccarone, MD, MPH

State and Substate Estimates of Nonmedical Use of Prescription Pain Relievers

2017

Rachel N. Lipari, Ph.D., Struther L. Van Horn, M.A., Arthur Hughes, M.S. and, Matthew Williams, Ph.D.

The 2015 Heroin Signature Program Report: DEA Intelligence Report

2017

DEA

The Role of Science in Addressing the Opioid Crisis

2017

Nora D. Volkow, M.D., and Francis S. Collins, M.D., Ph.D.

Trends in Deaths Involving Heroin and Synthetic Opioids Excluding Methadone, and Law Enforcement Drug Product Reports, by Census Region — United States, 2006–2015

2017

Julie K. O’Donnell, PhD1; R. Matthew Gladden, PhD1; Puja Seth, PhD

Vital Signs: Trends in Emergency Department Visits for Suspected Opioid Overdoses — United States, July 2016–September 2017

2018

Alana M. Vivolo-Kantor, PhD1; Puja Seth, PhD1; R. Matthew Gladden, PhD1; Christine L. Mattson, PhD1; Grant T. Baldwin, PhD1; Aaron Kite-Powell, MS2; Michael A. Coletta, MPH

Trends in the Use of Methadone, Buprenorphine, and Extended-Release Naltrexone at Substance Abuse Treatment Facilities: 2003-2015 (UPDATE)

2017

Cathie E. Alderks, Ph.D.

The Future of Fentanyl and Other Synthetic Opioids

2019

Bryce Pardo, Jirka Taylor, Jonathan P. Caulkins, Beau Kilmer, Peter Reuter, Bradley D. Stein

Understanding America's Surge in Fentanyl and Other Synthetic Opioids

2019

Bryce Pardo, Jirka Taylor, Jonathan P. Caulkins, Beau Kilmer, Peter Reuter, Bradley D. Stein

Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality

2018

Marc R. Larochelle, MD, MPH, Dana Bernson, MPH, Thomas Land, PhD, Thomas J. Stopka, PhD, MHS, Na Wang, MA, Ziming Xuan, ScD, SM, Sarah M. Bagley, MD, MSc, Jane M. Liebschutz, MD, MPH, Alexander Y. Walley, MD, MSc

Unintentional Fentanyl Overdoses Among Persons Who Thought Ther Were Snorting Cocaine - Fresno, CA - January 7, 2019

2019

Patil Armenian, MD; Jeffrey D. Whitman, MD; Adina Badea, PhD; Whitney Johnson, MD; Chelsea Drake, MS; Simranjit Singh Dhillon; Michelle Rivera; Nicklaus Brandehoff, MD; Kara L. Lynch, PhD

Risk Factors for Opioid-Use Disorder and Overdose

2017

Lynn R. Webster

Barriers Rural Physicians Face Prescribing Buprenorphine for Opioid Use Disorder

2017

C. Holly A. Andrilla, Cynthia Coulthard and Eric H. Larson

Medication-Assisted Treatment of Opioid Use Disorder. Review of the Evidence and Future Directions

2015

Connery, Hilary Smith MD, PhD

Confronting the Stigma of Opioid Use Disorder—and Its Treatment

2014

Yngvild Olsen, MD, MPH; Joshua M. Sharfstein, MD

The Impact of Substance Use Disorders on Families and Children: From Theory to Practice

2013

Laura Lander, Janie Howsare, and Marilyn Byrne